Cite
MLA Citation
R. Landewé et al.. “OP0334 Efficacy and safety of continuing versus withdrawing adalimumab (ADA) in maintaining remission in patients with non-radiographic axial spondyloarthritis (NR-AXSPA).” Annals of the rheumatic diseases, vol. 77, n.d., p. 213. http://access.bl.uk/ark:/81055/vdc_100144723042.0x00004c